Leo K. Niskanen
Kuopio, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Nationwide Real-World Retrospective Study of Oral Semaglutide Use in Adults Living With Type 2 Diabetes in Finland.
Journal: Diabetes, obesity & metabolism
Published: January 09, 2026
Diabetes and Cancer-Specific Survival: A Nationwide Population-Based Cohort Study Across Multiple Cancer Sites.
Journal: Cancer reports (Hoboken, N.J.)
Published: November 05, 2025
A pharmacoepidemiological nested case-control study of risk factors for venous thromboembolism with the focus on diabetes, cancer, socioeconomic group, medications, and comorbidities.
Journal: Diabetes & vascular disease research
Published: June 21, 2024
Renal Hyperfiltration as a New Mechanism of Smoking-Related Mortality.
Journal: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Published: February 10, 2024
Does the duration of diabetes increase the risk of cancer? A nationwide population-based cohort of patients with new-onset diabetes and a matched reference cohort.
Journal: International journal of cancer
Published: October 18, 2023
Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study.
Journal: Journal of diabetes research
Published: September 19, 2023
Trends and burden of diabetes in patients with atrial fibrillation during 2007-2018: A Finnish nationwide cohort study.
Journal: Diabetes research and clinical practice
Published: July 06, 2023
Chronic kidney disease stage is associated with the number of risk factors in type 2 diabetes patients (STages Of NEphropathy in type 2 diabetes and Heart Failure - STONE HF).
Journal: Primary care diabetes
Published: June 19, 2023
Trends in clinical characteristics, medication use, and glycemic control in insulin-treated patients with type 1 and type 2 diabetes in Finland in 2012-2019: Nationwide real-world evidence study.
Journal: Journal of diabetes
Published: May 02, 2023
Metabolites and depressive symptoms: Network- and longitudinal analyses from the Finnish Depression and Metabolic Syndrome in Adults (FDMSA) Study.
Journal: Journal of affective disorders
Published: March 16, 2023
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia.
Journal: Cardiovascular diabetology
Published: February 17, 2023
Last Updated: 09/26/2026